Di Yi Cai Jing Zi Xun·2026-01-26 09:11Group 1 - The core viewpoint of the article highlights a surge in stock prices of companies related to nucleic acid and antigen testing, such as Maike Biological (300463.SZ) and Zhijiang Biological (688317.SH), following reports of Nipah virus infections in India [2] - The Nipah virus has a high mortality rate of over 40% and can cause severe symptoms, including fever, headache, and confusion, raising concerns about its potential spread and the risk of imported cases [2][3] - The Nipah virus, first identified in Malaysia in 1998, has caused significant outbreaks in various countries, leading to serious public health threats and economic losses in the pig farming industry [3] Group 2 - There is currently no specific vaccine or effective treatment for the Nipah virus, with management relying on supportive care [3] - Experts indicate that while the Nipah virus can be transmitted between humans, the risk is low and typically requires close contact with infected individuals or animals [4] - The primary transmission routes include consumption of contaminated fruits or syrups and transmission from bats to pigs, then to humans [4]